|
1
|
Klatka J, Grywalska E, Klatka M, Wasiak M,
Andrzejczak A and Rolinski J: Expression of selected regulatory
molecules on the CD83+ monocyte-derived dendritic cells generated
from patients with laryngeal cancer and their clinical
significance. Eur Arch Otorhinolaryngol. 270:2683–2693. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gilbert K, Dalley RW, Maronian N and Anzai
Y: Staging of laryngeal cancer using 64-channel multidetector row
CT: Comparison of standard neck CT with dedicated breath-maneuver
laryngeal CT. AJNR Am J Neuroradiol. 31:251–256. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Divi V, Worden FP, Prince ME, Eisbruch A,
Lee JS, Bradford CR, Chepeha DB, Teknos TN, Hogikyan ND, Moyer JS,
et al: Chemotherapy alone for organ preservation in advanced
laryngeal cancer. Head Neck. 32:1040–1047. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mouw KW, Solanki AA, Stenson KM, Witt ME,
Blair EA, Cohen EE, Vokes EE, List M, Haraf DJ and Salama JK:
Performance and quality of life outcomes for T4 laryngeal cancer
patients treated with induction chemotherapy followed by
chemoradiotherapy. Oral Oncol. 48:1025–1030. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ampil FL and Nguyen NP: Defining ‘upper
mediastinal irradiation’ in secondary subglottic laryngeal cancer.
Oral Oncol. 50:e15–e16. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Janssens GO, van Bockel LW, Doornaert PA,
Bijl HP, van den Ende P, de Jong MA, van den Broek GB, Verbist BM,
Terhaard CH, Span PN and Kaanders JH: Computed tomography-based
tumour volume as a predictor of outcome in laryngeal cancer:
Results of the phase 3 ARCON trial. Eur J Cancer. 50:1112–1119.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vachhani P, Bose P, Rahmani M and Grant S:
Rational combination of dual PI3K/mTOR blockade and Bcl-2/−xL
inhibition in AML. Physiol Genomics. 46:448–456. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yu X and Li Z: The role of MicroRNAs
expression in laryngeal cancer. Oncotarget. 6:23297–23305. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang Y, Chen Y, Yu J, Liu G and Huang Z:
Integrated transcriptome analysis reveals miRNA-mRNA crosstalk in
laryngeal squamous cell carcinoma. Genomics. 104:249–256. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu W, Geng H, Liu Z, Li H and Zhu Z:
Effect of curcumin on rats/mice with diabetic nephropathy: A
systematic review and meta-analysis of randomized controlled
trials. J Tradit Chin Med. 34:419–429. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Koprowski S, Sokolowski K, Kunnimalaiyaan
S, Gamblin TC and Kunnimalaiyaan M: Curcumin-mediated regulation of
Notch1/hairy and enhancer of split-1/survivin: Molecular targeting
in cholangiocarcinoma. J Surg Res. 198:434–440. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
He Y, Yue Y, Zheng X, Zhang K, Chen S and
Du Z: Curcumin, inflammation and chronic diseases: How are they
linked? Molecules. 20:9183–9213. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhu L, Han MB, Gao Y, Wang H, Dai L, Wen Y
and Na LX: Curcumin triggers apoptosis via upregulation of
Bax/Bcl-2 ratio and caspase activation in SW872 human adipocytes.
Mol Med Rep. 12:1151–1156. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zubillaga-Guerrero MI, Alarcón-Romero Ldel
C, Illades-Aguiar B, Flores-Alfaro E, Bermúdez-Morales VH, Deas J
and Peralta-Zaragoza O: MicroRNA miR-16-1 regulates CCNE1 (cyclin
E1) gene expression in human cervical cancer cells. Int J Clin Exp
Med. 8:15999–16006. 2015.PubMed/NCBI
|
|
15
|
Koskinen WJ, Brøndbo K, Dahlstrand Mellin
H, Luostarinen T, Hakulinen T, Leivo I, Molijn A, Quint WG,
Røysland T, Munck-Wikland E, et al: Alcohol, smoking and human
papillomavirus in laryngeal carcinoma: A Nordic prospective
multicenter study. J Cancer Res Clin Oncol. 133:673–678. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hamilton DW, de Salis I, Donovan JL and
Birchall M: The recruitment of patients to trials in head and neck
cancer: A qualitative study of the EaStER trial of treatments for
early laryngeal cancer. Eur Arch Otorhinolaryngol. 270:2333–2337.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tuorkey MJ: Curcumin a potent cancer
preventive agent: Mechanisms of cancer cell killing. Interv Med
Appl Sci. 6:139–146. 2014.PubMed/NCBI
|
|
18
|
Sordillo PP and Helson L: Curcumin and
cancer stem cells: Curcumin has asymmetrical effects on cancer and
normal stem cells. Anticancer Res. 35:599–614. 2015.PubMed/NCBI
|
|
19
|
Hosseini A, Sharifi AM, Abdollahi M,
Najafi R, Baeeri M, Rayegan S, Cheshmehnour J, Hassani S, Bayrami Z
and Safa M: Cerium and yttrium oxide nanoparticles against
lead-induced oxidative stress and apoptosis in rat hippocampus.
Biol Trace Elem Res. 164:80–89. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Besbes S, Mirshahi M, Pocard M and Billard
C: New dimension in therapeutic targeting of BCL-2 family proteins.
Oncotarget. 6:12862–12871. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Moldoveanu T, Follis AV, Kriwacki RW and
Green DR: Many players in BCL-2 family affairs. Trends Biochem Sci.
39:101–111. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bitting RL and Armstrong AJ: Targeting the
PI3K/Akt/mTOR pathway in castration-resistant prostate cancer.
Endocr Relat Cancer. 20:R83–R99. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Simpson DR, Mell LK and Cohen EE:
Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of
the head and neck. Oral Oncol. 51:291–298. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Seo BR, Min KJ, Cho IJ, Kim SC and Kwon
TK: Curcumin significantly enhances dual PI3K/Akt and mTOR
inhibitor NVP-BEZ235-induced apoptosis in human renal carcinoma
Caki cells through down-regulation of p53-dependent Bcl-2
expression and inhibition of Mcl-1 protein stability. PLoS One.
9:e955882014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhao Z, Li C, Xi H, Gao Y and Xu D:
Curcumin induces apoptosis in pancreatic cancer cells through the
induction of forkhead box O1 and inhibition of the PI3K/Akt
pathway. Mol Med Rep. 12:5415–5422. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li L, Zhang ZM, Liu Y, Wei MH, Xue LY, Zou
SM, Di XB, Han NJ, Zhang KT, Xu ZG and Gao YN: DNA
microarrays-based microRNA expression profiles derived from
formalin-fixed paraffin-embedded tissue blocks of squammous cell
carcinoma of larynx. Zhonghua Bing Li Xue Za Zhi. 39:391–395.
2010.(In Chinese). PubMed/NCBI
|
|
27
|
Skawran B, Steinemann D, Becker T, Buurman
R, Flik J, Wiese B, Flemming P, Kreipe H, Schlegelberger B and
Wilkens L: Loss of 13q is associated with genes involved in cell
cycle and proliferation in dedifferentiated hepatocellular
carcinoma. Mod Pathol. 21:1479–1489. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang J, Cao Y, Sun J and Zhang Y: Curcumin
reduces the expression of Bcl-2 by upregulating miR-15a and miR-16
in MCF-7 cells. Med Oncol. 27:1114–1118. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gao SM, Yang JJ, Chen CQ, Chen JJ, Ye LP,
Wang LY, Wu JB, Xing CY and Yu K: Pure curcumin decreases the
expression of WT1 by upregulation of miR-15a and miR-16-1 in
leukemic cells. J Exp Clin Cancer Res. 31:272012. View Article : Google Scholar : PubMed/NCBI
|
